Clinical symptoms in benign prostatic hyperplasia (BPH) & for reduced urinary flow associated w/ BPH. May be used in BPH patients who are either hypertensive or normotensive.
4 mg daily. Optimal effect may take up to 4 wk, if necessary, may increase dose following this period to 8 mg once daily according to patient response. Max: 8 mg once daily.
Postural hypotension evidence by dizziness & weakness or syncope (rarely) w/ the commencement of therapy. Preexisting severe GI narrowing (pathologic or iatrogenic). Intraoperative floppy iris syndrome during cataract surgery in patients on or previously treated w/ α1-blockers. Prolonged erections & priapism. Concomitant use w/ PDE-5 inhibitors. May impair ability to engage in activities eg, operating machinery or motor vehicle. Impaired hepatic function. Pregnancy & lactation.
C02CA04 - doxazosin ; Belongs to the class of alpha-adrenoreceptor antagonists, peripherally-acting antiadrenergic agents. Used in the treatment of hypertension.